115 related articles for article (PubMed ID: 9396618)
21. The antitumor efficacy of monomeric disintegrin obtustatin in S-180 sarcoma mouse model.
Ghazaryan N; Movsisyan N; Macedo JC; Vaz S; Ayvazyan N; Pardo L; Logarinho E
Invest New Drugs; 2019 Oct; 37(5):1044-1051. PubMed ID: 30680583
[TBL] [Abstract][Full Text] [Related]
22. A structure-activity analysis of antagonism of the growth factor and angiogenic activity of basic fibroblast growth factor by suramin and related polyanions.
Braddock PS; Hu DE; Fan TP; Stratford IJ; Harris AL; Bicknell R
Br J Cancer; 1994 May; 69(5):890-8. PubMed ID: 7514028
[TBL] [Abstract][Full Text] [Related]
23. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis.
Fujita M; Hayashi I; Yamashina S; Itoman M; Majima M
Biochem Biophys Res Commun; 2002 Jun; 294(2):441-7. PubMed ID: 12051731
[TBL] [Abstract][Full Text] [Related]
24. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
Boylan M; van den Berg HW; Lynch M
Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
[TBL] [Abstract][Full Text] [Related]
25. Eriochrome black T inhibition of human skin collagenase, but not gelatinase, using both protein and synthetic substrates.
Seltzer JL; Eschbach ML; Winberg JO; Bauer EA; Eisen AZ; Weingarten H
Coll Relat Res; 1987 Dec; 7(6):399-407. PubMed ID: 2833373
[TBL] [Abstract][Full Text] [Related]
26. [The enhancement of the chemotherapeutic effects on human prostate cancer cell--the combination with the growth factor interaction inhibitor (suramin)].
Suzuki Y; Miwa Y; Akino H; Fujita T; Saikawa S; Kanimoto Y; Okada K
Hinyokika Kiyo; 1993 Dec; 39(12):1215-20. PubMed ID: 8285172
[TBL] [Abstract][Full Text] [Related]
27. Suramin selectively inhibits carcinoma cell growth that is dependent on extracellular polyamines.
Sandgren S; Belting M
Anticancer Res; 2003; 23(2B):1223-8. PubMed ID: 12820375
[TBL] [Abstract][Full Text] [Related]
28. Effects of suramin on cell-cycle kinetics of MCF-7 human breast cancer cells in vitro.
Foekens JA; Sieuwerts AM; Stuurman-Smeets EM; Peters HA; Klijn JG
Br J Cancer; 1993 Feb; 67(2):232-6. PubMed ID: 8431356
[TBL] [Abstract][Full Text] [Related]
29. Suramin. A potent inhibitor of melanoma heparanase and invasion.
Nakajima M; DeChavigny A; Johnson CE; Hamada J; Stein CA; Nicolson GL
J Biol Chem; 1991 May; 266(15):9661-6. PubMed ID: 2033058
[TBL] [Abstract][Full Text] [Related]
30. Antiproliferative effect of suramin on primary cultures of human pheochromocytomas and rat PC12 pheochromocytoma cells.
Zielke A; Wong MG; Siperstein AE; Clark OH; Rothmund M; Duh QY
J Surg Oncol; 1997 Sep; 66(1):11-8. PubMed ID: 9290687
[TBL] [Abstract][Full Text] [Related]
31. In vitro sequence-dependent synergistic effect of suramin and camptothecin.
Lopez R; Peters GJ; Smitskamp-Wilms E; Virizuela JA; van Ark-Otte J; Pinedo HM; Giaccone G
Eur J Cancer; 1994; 30A(11):1670-4. PubMed ID: 7833142
[TBL] [Abstract][Full Text] [Related]
32. Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer.
Thalmann GN; Sikes RA; Chang SM; Johnston DA; von Eschenbach AC; Chung LW
J Natl Cancer Inst; 1996 Jun; 88(12):794-801. PubMed ID: 8637045
[TBL] [Abstract][Full Text] [Related]
33. Suramin, an anti-cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2A.
Hensey CE; Boscoboinik D; Azzi A
FEBS Lett; 1989 Nov; 258(1):156-8. PubMed ID: 2591531
[TBL] [Abstract][Full Text] [Related]
34. Suramin prevents neovascularisation and tumour growth through blocking of basic fibroblast growth factor activity.
Pesenti E; Sola F; Mongelli N; Grandi M; Spreafico F
Br J Cancer; 1992 Aug; 66(2):367-72. PubMed ID: 1380282
[TBL] [Abstract][Full Text] [Related]
35. Different ways to antiangiogenesis by angiostatin and suramin, and quantitation of angiostatin-induced antiangiogenesis.
Bahramsoltani M; Plendl J
APMIS; 2007 Jan; 115(1):30-46. PubMed ID: 17223849
[TBL] [Abstract][Full Text] [Related]
36. Complete inhibition of human ovarian cancer xenografts in nude mice by suramin and cis-diamminedichloroplatinum(II).
Kikuchi Y; Hirata J; Hisano A; Tode T; Kita T; Nagata I
Gynecol Oncol; 1995 Jul; 58(1):11-5. PubMed ID: 7789875
[TBL] [Abstract][Full Text] [Related]
37. Suramin sodium: pronounced effects on methotrexate transport and anti-folate activity in cultured tumor cells.
Rideout DC; Bustamante A; Patel R; Henderson GB
Int J Cancer; 1995 Jun; 61(6):840-7. PubMed ID: 7790120
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of glycosylphosphatidylinositol (GPI) phospholipase D by suramin-like compounds.
Brunner G; Zalkow L; Burgess E; Rifkin DB; Wilson EL; Gruszecka-Kowalik E; Powis G
Anticancer Res; 1996; 16(5A):2513-6. PubMed ID: 8917344
[TBL] [Abstract][Full Text] [Related]
39. Effect of Eriochrome Black T on the gelatinization of xyloglucan investigated using rheological measurement and release behavior of Eriochrome Black T from xyloglucan gel matrices.
Hirun N; Tantishaiyakul V; Pichayakorn W
Int J Pharm; 2010 Mar; 388(1-2):196-201. PubMed ID: 20074631
[TBL] [Abstract][Full Text] [Related]
40. [Suramin activity in human head and neck squamous cell carcinoma cell lines].
Li AT
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(2):108-9, 125. PubMed ID: 8217281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
